– | – | Male | Female |
---|---|---|---|
Hb (g/dl) | patient | 12.38 ± 0.75** | 11.13 ±1.52** |
control | 15.21± 0.77 | 12.98 ± 0.98 | |
HCT (l/l) | patient | 38.55 ± 2.79** | 34.36 ± 4.13** |
control | 44.48 ± 1.74 | 37.9 ± 2.71 | |
MCV (fl) | patient | 78.65 ± 5.83** | 79.21 ± 7.97** |
control | 85.50 ± 2.53 | 85.23 ± 3.85 | |
MCH (pg) | patient | 25.79 ± 2.33** | 25.06 ± 3.28** |
control | 29.58 ±1.02 | 29.36 ± 1.32 | |
RDW (%) | patient | 13.84 ±2.68** | 13.49 ± 2.03** |
control | 10.41 ±0.54 | 11.36 ± 1.01 | |
CRP (mg/l) | patient | 10.66 ±3.2** | 6.99 ±4.52** |
control | 1.18 ± 0.99 | 1.24 ± 1.18 | |
S iron (μg/dl) | patient | 34.800 ± 16.70** | 41.500 ±18.4** |
control | 108.14 ±30.68 | 82.82 ± 21.83 | |
TIBC (μg/dl) | patient | 244.60 ±99.26* | 313.42 ±74.25* |
control | 349.57 ±37.92 | 348.73 ±34.41 | |
Transferrin saturation (%) | patient | 15.60 ± 5.95** | 14.06 ±6.24** |
control | 30.65 ± 6.87 | 23.80 ± 6.15 | |
Serum Ferritin (µg/l) | patient | 93.38 ± 76.07 | 87.11 ± 132.84 |
control | 113.18 ± 83.93 | 42.64 ±26.94 | |
sTfR (mg/l) | patient | 2.38 ±1.28 | 2.26 ±1.13* |
control | 1.61 ±0.51 | 1.70 ±0.62 | |
sTfR-F index | patient | 1.11 ±0.44 | 1.78 ±1.67* |
control | 0.85 ± 0.26 | 0.99 ± 0.40 | |
*: p<0.05, **: p<0.0` |